HOME >> BIOLOGY >> NEWS
Ancient origins found in arabidopsis genome

3.html">http://www.ncbi.nlm.nih.gov/Education/BLASTinfo/information3.html

o USDA-ARS Center for Agricultural Bioinformatics at Cornell: http://genome.cornell.edu/index.html

How Cornell's computing resources help to "blast" against databases

Running a massive BLAST search on the Arabidopsis genome was easier for Cornell University researcher Todd Vision than it might have been for many other genomics researchers, thanks to the Cornell Theory Center (CTC). The center maintains a special computing resource in Rhodes Hall on the Cornell campus in conjunction with the U.S. Department of Agriculture's Center for Agricultural Bioinformatics (CAB).

The resource, loosely named the 'genomics cluster,' consists of 12 computers, each made up of four 500-Mhz Pentium III processors running the Windows 2000 operating system. With software developed for CTC, eight of the machines run as a parallel-processing cluster, effectively a supercomputer.

The cluster is primarily used for searches using BLAST (an acronym for Basic Local Alignment Search Tool), a program that searches gene and protein databases for pattern matches, much the same way a text searcher will match words and phrases. BLAST servers are available elsewhere to the worldwide research community through World Wide Web interfaces, but they are not suitable for running a large batch of queries such as the one Vision used to track the genetic history of Arabidopsis .

The BLAST server on the Web takes one query and "blasts" it against the database, Vision explained. "But I needed to run twenty-something thousand proteins. Imagine sitting there and clicking the mouse that many times. Doing it on Theory Center computers allowed us to do it in a batch. Doing it all on local computers allows you more speed, more flexibility and less hands-on processing."

Vision also assembled on a Theory Center computer a specia
'"/>

Contact: Blaine P. Friedlander Jr.
bpf2@cornell.edu
607-255-3290
Cornell University News Service
14-Dec-2000


Page: 1 2 3 4 5

Related biology news :

1. Ancient life form may help create newest technologies
2. Ancient brewery discovered on mountaintop in Peru
3. Ancient Greeks help scientists build environmentally friendly nano devices
4. Ancient DNA mutations permitted humans to adapt to colder climates, UCI researchers find
5. Ancient Inca road in desperate need of protection
6. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man
7. Ancient pollen yields insight into forest biodiversity
8. Ancient defense mechanism may still be protecting us
9. Ancient flower fossil points to underwater origins
10. Ancient supernova may have triggered eco-catastrophe
11. Ancient Chinese folk remedy may hold key to non-toxic cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ancient origins found arabidopsis genome

(Date:12/4/2014)... Fla. , Dec. 3, 2014  Crossmatch™, ... today announced that its DigitalPersona ® Pro ... readers have been deployed throughout First Bank branch ... South Carolina and Virginia. First ... Southern Pines, North Carolina , ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... New York College, and one of the most prolific ... signals that are transmitted from Smartphones to third party ... Smartphones and has one of the earliest known patents ... its usage in the military, child care, elder care ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure Identity ... Association today jointly announce the formation of The ... of its Identity and Biometric Entry and ... Framework received official support from BORDERPOL, the international ... improve and provide expertise regarding border security, traveler ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... 17, 2014   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, announced today its presentation at ... San Francisco, CA. ... Officer, will present on Monday, January 12, 2015, at ... be webcast live and may be accessed from the ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: